CPT 88368Laboratory

Insitu hybridization manual

CPT code 88368 covers manual in situ hybridization testing, a laboratory technique that detects specific DNA or RNA sequences in tissue samples to identify genetic abnormalities, infections, or cancer markers.

Showing rates for

National Average

Base Medicare rate

$144.59

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.88

PE RVU (NF)

3.56

MP RVU

0.03

Total RVU

4.47

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Report 88368 per specimen and per probe set, not per slide analyzed
Impact: Overbilling per slide can trigger audits and recoupment; underbilling loses $144.59 per unreported probe set
Verify LCD/NCD coverage requirements before performing test, particularly for Medicare beneficiaries requiring HER2 or other oncology-related ISH
Impact: Non-covered indications result in 100% denial; proper medical necessity documentation ensures full $144.59 reimbursement
Document manual methodology explicitly in pathology report to differentiate from automated ISH (88377) which has different reimbursement
Impact: Prevents downcoding to incorrect procedure code; maintains appropriate payment level
Link appropriate ICD-10 codes indicating medical necessity such as malignant neoplasm codes or suspected viral infection
Impact: Missing or non-specific diagnosis codes cause 15-30% of denials; proper linkage ensures first-pass payment
Bill technical and professional components separately when applicable, using TC and 26 modifiers appropriately based on contractual arrangements
Impact: Improper component billing can result in 50% underpayment or claim rejection
Maintain probe validation records and quality control documentation as part of CLIA compliance for high-complexity testing
Impact: Missing QC documentation during audits can trigger $144.59 recoupment per test plus CLIA sanctions

Common denials

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88368?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT code 88368 in 2025?

The 2025 Medicare national average reimbursement rate for CPT 88368 is $144.59 for both facility and non-facility settings. This rate is based on 4.47 total RVUs multiplied by the 2025 conversion factor of 32.3465.

What is the difference between CPT 88368 and 88377?

CPT 88368 is for manual in situ hybridization requiring hands-on technologist interpretation and microscopic counting, while 88377 is for automated ISH using computerized image analysis systems. The methodology used determines the correct code, and documentation must clearly specify which approach was employed.

How many times can I bill CPT 88368 per specimen?

Bill 88368 once per probe or probe set per specimen. If multiple different probes are used on the same specimen to answer distinct clinical questions, each may be separately billable with appropriate modifier 59, but documentation must clearly justify the medical necessity of each probe.

Does CPT 88368 require a QW modifier for CLIA-waived testing?

No, manual in situ hybridization (88368) is classified as high-complexity testing under CLIA regulations and cannot be CLIA-waived. The QW modifier is not applicable, and laboratories must maintain high-complexity CLIA certification to perform this test.

What documentation is required to bill CPT 88368 to Medicare?

Required documentation includes specimen identification, specific probe details, manual methodology description, number of cells analyzed, scoring criteria, interpretation results, quality control data, and medical necessity justification. The pathology report must clearly indicate manual rather than automated analysis.

Can CPT 88368 be billed with a professional component modifier 26?

CPT 88368 is primarily a technical component code representing the laboratory procedure itself. Most pathology interpretation is included in the base code. Modifier 26 is rarely appropriate unless specific contractual arrangements separate the technical and professional components.

What are common medical necessity requirements for CPT 88368?

Medical necessity typically requires prior pathology findings (H&E or immunohistochemistry) suggesting need for molecular confirmation, such as HER2 equivocal IHC results in breast cancer, suspected gene amplifications in solid tumors, or viral detection in infectious disease workup. Payer LCDs specify covered indications.